Blueberries Medical Corp.
BBRRF
$0.009
-$0.0023-20.35%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 59.59% | -7.69% | -7.39% | 5.16% | 18.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.59% | -7.69% | -7.39% | 5.16% | 18.65% |
| Cost of Revenue | 46.63% | -25.33% | -19.81% | -41.98% | -32.95% |
| Gross Profit | 91.19% | 20.66% | 29.83% | 486.16% | 237.14% |
| SG&A Expenses | -26.85% | -6.01% | -9.34% | -5.21% | -10.67% |
| Depreciation & Amortization | -30.94% | 5.46% | 26.05% | -30.69% | -51.82% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.20% | -7.48% | -7.66% | -14.50% | -20.09% |
| Operating Income | 34.52% | 7.41% | 7.71% | 17.98% | 25.20% |
| Income Before Tax | 31.01% | 9.77% | 18.53% | 10.21% | 12.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.01% | 9.77% | 18.53% | 10.21% | 12.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.01% | 9.77% | 18.53% | 10.21% | 12.97% |
| EBIT | 34.52% | 7.41% | 7.71% | 17.98% | 25.20% |
| EBITDA | 35.06% | 1.17% | 5.30% | 10.34% | 15.12% |
| EPS Basic | 62.50% | 37.21% | 42.62% | 32.35% | 34.12% |
| Normalized Basic EPS | 64.52% | 48.00% | 57.14% | 46.81% | 46.55% |
| EPS Diluted | 62.50% | 37.21% | 42.62% | 32.35% | 34.12% |
| Normalized Diluted EPS | 64.52% | 48.00% | 57.14% | 46.81% | 46.55% |
| Average Basic Shares Outstanding | 81.95% | 69.16% | 57.88% | 44.91% | 29.85% |
| Average Diluted Shares Outstanding | 81.95% | 69.16% | 57.88% | 44.91% | 29.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |